Cargando…
Boosting the Immune System for HIV Cure: A γδ T Cell Perspective
The major barrier to HIV cure is a population of long-lived cells that harbor latent but replication-competent virus, are not eliminated by antiretroviral therapy (ART), and remain indistinguishable from uninfected cells. However, ART does not cure HIV infection, side effects to treatment still occu...
Autores principales: | Mann, Brendan T., Sambrano, Edward, Maggirwar, Sanjay B., Soriano-Sarabia, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248175/ https://www.ncbi.nlm.nih.gov/pubmed/32509594 http://dx.doi.org/10.3389/fcimb.2020.00221 |
Ejemplares similares
-
HIV Latency in Myeloid Cells: Challenges for a Cure
por: Chitrakar, Alisha, et al.
Publicado: (2022) -
Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis
por: Zou, Shi, et al.
Publicado: (2022) -
Editorial: Immunotherapies Towards HIV Cure
por: Salgado, Maria, et al.
Publicado: (2021) -
Measuring the Success of HIV-1 Cure Strategies
por: Thomas, Jordan, et al.
Publicado: (2020) -
Editorial: Exploring Novel Approaches to Eliminate HIV Reservoirs to Achieve a Cure for HIV
por: van der Sluis, Renée M., et al.
Publicado: (2021)